Synopsys Stock News

Stratasys (SSYS) enhances personalized healthcare capabilities with the addition of Digital Anatomy Creator software to its medical modeling offerings.

Synopsys' (SNPS) Q4 results are likely to reflect solid demand for its product portfolio on rising adoption of AI, 5G, Internet of things, high-performance cloud computing and automotive.

VMW vs. SNPS: Which Stock Is the Better Value Option?

Synopsys (NASDAQ:SNPS) is set to give its latest quarterly earnings report on Wednesday, 2021-12-01. Here's what investors need to know before the announcement.

Synopsys (NASDAQ:SNPS) had its price objective increased by Credit Suisse Group from $300.00 to $360.00 in a research report sent to investors on Monday, The Fly reports. Credit Suisse Group currently has an outperform rating on the semiconductor companys stock. SNPS has been the subject of several other reports. Robert W. Baird raised their price []

Credit Suisse analyst John Pitzer raised the price target on Synopsys Inc (NASDAQ:SNPS) to $360 from $300, implying a 5.2% upside, and reiterated an Outperform ahead of quarterly results.  The a

Tributary Capital Management LLC decreased its holdings in Synopsys, Inc. (NASDAQ:SNPS) by 10.0% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 9,000 shares of the semiconductor companys stock after selling 1,000 shares during the quarter. Tributary Capital Management LLCs holdings in Synopsys were []

Equities research analysts expect Synopsys, Inc. (NASDAQ:SNPS) to announce earnings per share of $1.78 for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for Synopsys earnings, with the lowest EPS estimate coming in at $1.77 and the highest estimate coming in at $1.79. Synopsys posted earnings of $1.58 per share in []

Newfound Research LLC lifted its position in Synopsys, Inc. (NASDAQ:SNPS) by 27.9% during the third quarter, HoldingsChannel.com reports. The fund owned 344 shares of the semiconductor companys stock after acquiring an additional 75 shares during the period. Newfound Research LLCs holdings in Synopsys were worth $103,000 at the end of the most recent reporting period. []

Synopsys (NASDAQ:SNPS) had its target price raised by equities researchers at Wells Fargo & Company from $340.00 to $400.00 in a report issued on Tuesday, The Fly reports. The brokerage presently has an “overweight” rating on the semiconductor company’s stock. Wells Fargo & Company‘s price target points to a potential upside of 14.54% from the […]

Synopsys (SNPS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The shares of Synopsys, Inc. (NASDAQ: SNPS) have received a $400 price target from Wells Fargo. These are the details.

President and co-Chief Executive Officer of Synopsys Dr. Chi Foon Chan has visited the Armenian Genocide Memorial.

Wedbush Securities Inc. cut its position in Synopsys, Inc. (NASDAQ:SNPS) by 4.0% in the third quarter, HoldingsChannel.com reports. The firm owned 6,233 shares of the semiconductor companys stock after selling 259 shares during the period. Wedbush Securities Inc.s holdings in Synopsys were worth $1,866,000 as of its most recent SEC filing. A number of other []